Literature DB >> 23347611

320-row computed tomography coronary angiography vs. conventional coronary angiography in patients with suspected coronary artery disease: a systematic review and meta-analysis.

Carlo Gaudio1, Francesco Pelliccia, Antonietta Evangelista, Gaetano Tanzilli, Vincenzo Paravati, Giuseppe Pannarale, Gaetano Pannitteri, Francesco Barillà, Cesare Greco, Ferdinando Franzoni, Giuseppe Speziale, Vincenzo Pasceri.   

Abstract

Entities:  

Keywords:  Computed tomography; Coronary angiography; Coronary artery disease

Mesh：

Year:  2013        PMID： 23347611     DOI： 10.1016/j.ijcard.2012.12.067

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

Review 1.  CT angiography in the diagnosis of cardiovascular disease: a transformation in cardiovascular CT practice.

Authors:  Zhonghua Sun; Mansour Al Moudi; Yan Cao
Journal:  Quant Imaging Med Surg       Date:  2014-10

Review 2.  Coronary CT angiography: Diagnostic value and clinical challenges.

Authors:  Akmal Sabarudin; Zhonghua Sun
Journal:  World J Cardiol       Date:  2013-12-26

3.  A novel ultrafast-low-dose computed tomography protocol allows concomitant coronary artery evaluation and lung cancer screening.

Authors:  Carlo Gaudio; Gennaro Petriello; Francesco Pelliccia; Alessandra Tanzilli; Alberto Bandiera; Gaetano Tanzilli; Francesco Barillà; Vincenzo Paravati; Massimo Pellegrini; Enrico Mangieri; Paolo Barillari
Journal:  BMC Cardiovasc Disord       Date:  2018-05-08       Impact factor: 2.298

4.  Concomitant screening of coronary artery disease and lung cancer with a new ultrafast-low-dose Computed Tomography protocol: A pilot randomised trial.

Authors:  Carlo Gaudio; Alessandra Tanzilli; Mariachiara Mei; Andrea Moretti; Francesco Barillà; Antonio Varveri; Vincenzo Paravati; Gaetano Tanzilli; Antonio Ciccaglioni; Stefano Strano; Massimo Pellegrini; Paolo Barillari; Francesco Pelliccia
Journal:  Sci Rep       Date:  2019-09-25       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.